In what could prove to be an important development in the search for a treatment of Alzheimer's disease, NewYork-Presbyterian Hospital/Weill Cornell Medical Center physician-scientists say the results of an initial (Phase I) clinical study provide encouraging evidence that antibodies derived from human plasma can capture the beta-amyloid protein in blood and exert positive effects on patients' thinking abilities.Read more at the Alzheimer's Reading Room: Newly Discovered Antibody May Be Body's Natural Defense Against Alzheimer's (Gammagard)
